Your browser doesn't support javascript.
A cross sectional study to examine factors influencing COVID-19 vaccine acceptance, hesitancy and refusal in urban and rural settings in Tamil Nadu, India.
Joshi, Ashish; Surapaneni, Krishna Mohan; Kaur, Mahima; Bhatt, Ashruti; Nash, Denis; El-Mohandes, Ayman.
  • Joshi A; City University of New York Graduate School of Public Health and Health Policy, New York, New York, United States of America.
  • Surapaneni KM; CUNY Institute for Implementation Science in Population Health, New York, New York, United States of America.
  • Kaur M; SMAART PHIC, Panimalar Medical College Hospital & Research Institute, Chennai, India.
  • Bhatt A; SMAART PHIC, Panimalar Medical College Hospital & Research Institute, Chennai, India.
  • Nash D; SMAART PHIC, Panimalar Medical College Hospital & Research Institute, Chennai, India.
  • El-Mohandes A; Foundation of Healthcare Technologies Society, Delhi, India.
PLoS One ; 17(6): e0269299, 2022.
Article in English | MEDLINE | ID: covidwho-2021778
ABSTRACT
The second wave of the COVID-19 pandemic left the Indian healthcare system overwhelmed. The severity of a third wave will depend on the success of the vaccination drive; however, even with a safe and effective COVID-19 vaccine, hesitancy can be an obstacle to achieving high levels of coverage. Our study aims to estimate the population's acceptance of the COVID-19 vaccine in an Indian district. A pilot community-based cross-sectional study was conducted from March-May 2021. The data was collected from eight primary health centres in Tamil Nadu. The eligible study participants were interviewed using a self-constructed questionnaire. A total of 3,130 individuals responded to the survey. Multinomial logistic regression was performed to assess the factors influencing COVID-19 vaccine hesitancy and refusal. Results of our study showed that 46% percent (n = 1432) of the respondents would accept the COVID-19 vaccine if available. Acceptance for the COVID-19 vaccine was higher among males (54%), individuals aged 18-24years (62%), those with higher education (77%), having the higher income (73%), and employed (51%). Individuals with no education (OR 2.799, 95% CI = 1.103-7.108), and low income (OR OR 10.299, 95% CI 4.879-21.741), were significant predictors of vaccine hesitancy (p < 0.05). Living in urban residence (OR 0.699, 95% CI = 0.55-0.888) and age between 18 to 25 years (OR 0.549, 95% CI = 0.309-0.977) were protective factor of COVID-19 vaccine hesitancy. While individuals in the age group 25-54years (OR = 1.601, 95%CI = 1.086-2.359), fewer education (OR = 4.8, 95% CI = 2.448-9.412,), low income (OR = 2.628, 95% CI = 1.777-3.887) and unemployment (OR = 1.351, 95% CI = 1.06-1.722) had high odds of refusing the COVID-19 vaccine. Concerns and suspicions about the safety of the COVID-19 vaccine (63%) was the major reasons causing hesitancy towards the COVID-19 vaccine The public health authorities and government need to design, develop and implement targeted interventions to enhance awareness about COVID-19 vaccines, and barriers and enablers to vaccine acceptance among individuals across diverse settings. Emphasis on involving local and religious leaders, ASHA workers, community healthcare workers, Anganwadi workers, and auxiliary nurse midwives can help to overcome context-specific barriers in areas of low COVID-19 vaccine acceptance, especially in rural settings.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Urination Disorders / COVID-19 Type of study: Etiology study / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adolescent / Adult / Humans / Male / Young adult Country/Region as subject: Asia Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0269299

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Urination Disorders / COVID-19 Type of study: Etiology study / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adolescent / Adult / Humans / Male / Young adult Country/Region as subject: Asia Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0269299